Orchid Pharma, a Chennai-based pharmaceutical company catering across the pharmaceutical value chain (discovery to delivery) with expertise in R&D and marketing, has announced the appointment of Chief Executive Officer, Rajnish Rohatgi, for its new division Orchid AMS. He will be responsible for setting up a new division focused on promoting the rational use of anti-infectives, to  favourably impact a key aspect of Indian public health.

Rohatgi is a seasoned leader and strategic thinker with over 35 years of experience in steering both B2C and B2B product and service businesses across sectors including consumer goods and healthcare.

He has held prominent positions at prominent companies like Unilever, Max Hospital, and Becton Dickinson, where his visionary leadership and entrepreneurial acumen delivered significant impact.

In 2022-23, Rohatgi consulted with Orchid Pharma and was instrumental in developing a unique strategy and business plan focused on entering the domestic formulations market, with a range of antibiotics. Recognising his exceptional expertise, Orchid Pharma invited him to join full-time, undertaking the challenge of building a successful business from the ground up.

Backed by a strong educational foundation from IIT Kanpur and IIM Calcutta, Rohatgi has cultivated a robust foundation in propelling business growth, fostering innovation, and spearheading strategic initiatives.